The formulation of halofantrine as either non-solubilising PEG 6000 or solubilising lipid based solid dispersions: Physical stability and absolute bioavailability assessment

Research output: Contribution to journalArticleResearchpeer-review

85 Citations (Scopus)
Original languageEnglish
Pages (from-to)65 - 78
Number of pages14
JournalInternational Journal of Pharmaceutics
Publication statusPublished - 2000

Cite this